Interinstitutional Center of Neurological Medicine, IRCCS C. Mondino National Neurological Institute, Via Mondino 2, 27100, Pavia, Italy.
CIRNA-Onlus Foundation, Pavia, Italy.
Aging Clin Exp Res. 2019 Apr;31(4):463-468. doi: 10.1007/s40520-018-0991-0. Epub 2018 Jun 29.
No study has evaluated the cardiovascular effects of diazepam in elderly subjects that assume diazepam to induce sleep.
The present study was carried out in order to evaluate the effects of chronic administration of diazepam as hypnotic drug on blood pressure (BP) and heart rate (HR) in healthy elderly subjects.
Healthy, elderly subjects, aged 65-74 years, were treated with diazepam 5 mg or placebo-both administered once a day in the evening-for 4 weeks in two cross-over periods, each separated by a 2-week placebo period, according to a randomized, double-blind, cross-over design. At the end of each study period, clinical as well as 24-h ambulatory BP and HR were evaluated.
A total of 25 subjects were included in the analysis. At the end of a 4-week diazepam treatment, clinical as well 24-h BP and HR mean values were not significantly affected. Analysis of sub-periods showed that during night-time, systolic BP (SBP) values under diazepam were 7.6% higher than under placebo, with a mean difference of 7.9 mmHg (p < 0.01), diastolic BP (DBP) values were 5.8% higher, with a mean difference of 3.7 mmHg (p < 0.05 vs placebo) and HR values were 6.6% higher with a mean difference of 4.2 b/min (p < 0.05). The HR increase observed with diazepam persisted during the morning hours, whereas during the afternoon and evening hours SBP, DBP and HR values were similar in the two treatment groups.
In elderly subjects chronic assumption of diazepam as hypnotic agent produced an increase in BP, in particular SBP, during night-time and of HR during night-time and morning hours. These effects, which probably depend on a diazepam-mediated increase in sympathetic drive and decrease in vagal tone, might be of clinical relevance due to the role of increased BP and HR as independent predictors of cardiovascular morbidity and mortality.
尚无研究评估安定在假定诱导睡眠的老年受试者中的心血管效应。
本研究旨在评估作为催眠药物的安定慢性给药对健康老年受试者的血压(BP)和心率(HR)的影响。
65-74 岁的健康老年受试者,在两个交叉周期中,每个周期间隔 2 周安慰剂期,每天晚上接受安定 5mg 或安慰剂治疗,均为 1 次/天,为期 4 周,采用随机、双盲、交叉设计。在每个研究期结束时,评估临床和 24 小时动态血压和 HR。
共有 25 名受试者纳入分析。在 4 周安定治疗结束时,临床和 24 小时 BP 和 HR 平均值未受到显著影响。亚时段分析显示,在夜间,SBP 值在安定下比安慰剂高 7.6%,平均差值为 7.9mmHg(p<0.01),DBP 值高 5.8%,平均差值为 3.7mmHg(p<0.05 与安慰剂相比),HR 值高 6.6%,平均差值为 4.2 b/min(p<0.05)。安定引起的 HR 升高在上午持续存在,而在下午和晚上,两组的 SBP、DBP 和 HR 值相似。
在老年受试者中,作为催眠剂的安定的慢性服用会导致夜间 BP 升高,尤其是 SBP 升高,以及夜间和上午 HR 升高。这些影响可能与安定介导的交感神经驱动增加和迷走神经张力降低有关,由于 BP 和 HR 增加是心血管发病率和死亡率的独立预测因素,因此可能具有临床相关性。